Lamotrigina Svus

Lamotrigine, the active ingredient in Lamotrigina Svus, is an anticonvulsant presented as an oral tablet for systemic use. It is employed to control seizures in epilepsy and to stabilize mood in bipolar disorder, addressing both partial and generalized seizure types. The drug works by modulating neuronal excitability, reducing the likelihood of abnormal electrical activity in the brain.

GNH USA supplies Lamotrigina Svus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal hyperexcitability.

Epilepsy: reduces the frequency and severity of seizures in patients with various seizure types. Bipolar disorder: helps prevent recurrence of depressive and manic episodes. Partial seizures: controls focal onset seizures with or without secondary generalization. Generalized seizures: diminishes tonic‑clonic and absence seizure activity.

Lamotrigine may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Dizziness - Headache - Nausea - Mild skin rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Aseptic meningitis - Severe skin reactions such as bullous eruptions

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risks.

Dose titration: increase gradually to reduce the risk of rash. Skin monitoring: watch for any rash, especially during the early weeks of therapy. Concomitant valproate: adjust lamotrigine dose as valproate can increase its plasma levels. Renal or hepatic impairment: may require dose adjustment based on organ function. Store below 25°C: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effects.

Major Interactions (Avoid): - Valproic acid: can double lamotrigine levels, requiring dose reduction. - Carbamazepine: can lower lamotrigine concentrations, potentially reducing efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating therapeutic monitoring. - Phenobarbital: may reduce lamotrigine concentrations. - Serotonergic agents: combined use may increase the rare risk of serotonin syndrome.